Patterns of the association among ultrasound, hemodynamic and biochemical parameters of atherosclerosis of the carotid and coronary arteries in patients with coronary heart disease

An increase in the proportion of comorbid cardiac patients with primary nosologies such as arterial hypertension and atherosclerosis actualizes the search for optimal approaches to their diagnosis and treatment. The emerging pathogenetic mechanisms of concomitant diseases must be taken into account on an individual basis. Aim of the study was to investigate the patterns of atherosclerotic changes in carotid arteries in patients with coronary heart disease who underwent percutaneous transluminal coronary angioplasty and their correlation with biochemical and hemodynamic markers of atherosclerosis. Material and methods. 53 patients with coronary heart disease (CHD) were examined and treated in the clinic of the Federal Research Center of Fundamental and Translational Medicine. The average age of the patients was 64.73 ± 1.66 years. A comprehensive clinical laboratory examination was conducted, including the blood lipids test to measure content of total cholesterol, low- and high-density lipoprotein cholesterol, triglycerides, as well as serum markers of systemic inflammation (concentration of C-reactive protein (CRP), fibrinogen, erythrocyte sedimentation rate (ESR)) and carotid artery duplex scan. Results. A direct correlation between the severity of atherosclerotic changes in the carotid arteries and indicators of systemic inflammation, i.e. CRP, ESR and fibrinogen was found. The study also revealed greater severity of atherosclerotic stenosis of the carotid arteries in patients with coronary artery disease who underwent percutaneous transluminal coronary angioplasty with coronary artery stenting compared to patients without any intervention. Conclusion. The obtained data indicate the effectiveness of ultrasound scan of the carotid arteries for the early diagnosis of multifocal atherosclerosis for timely treatment and prevention of cardiovascular polymorbidity in patients with a cardiovascular profile.

1. All-Russian public organization Association of general practitioners (family doctors). Section «Combined pathologies». Comorbid pathology in clinical practice: Clinical recommendations. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2017; 16 (6): 5–56. [In Russian]. doi: 10.15829/1728-8800-2017-6-5-56

2. Shishkova V.N., Kapustina L.A. Problems of a comorbid patient: how to choose the right statin. Effektivnaya farmakoterapiya = Effective Pharmacotherapy. 2017; (17): 14–23. [In Russian].

3. Alekyan B.G., Pokrovsky A.V., Karapetyan N.G., Revishvili A.Sh. Multidisciplinary approach in determining the frequency of detection of coronary heart disease and treatment strategies in patients with aortic and peripheral artery pathology. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2019; 24 (8): 8–16. [In Russian]. doi: 10.15829/1560-4071-2019-8-8-16

4. Nurgazizova A.K. Origin, development and modern interpretation of the concepts of «comorbidity» and «polymorbidity». Kazanskiy meditsinskiy zhurnal = Kazan Medical Journal. 2014; 95 (2): 292–296. [In Russian].

5. Shukurov F.B., Bulgakova E.S., Shapieva A.N., Rudenko B.A., Tvorogova T.V., Shanoyan A.S., Suvorov A.Yu., Feshchenko D.A., Chigidinova D.S., Vasiliev D.K., Kontsevaya A.V., Drapkina O.M. Dynamics of blood pressure level during 12 months after carotid stenting in patients with stenosing lesions of the carotid arteries. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2019; 24 (8): 17–21. [In Russian]. doi: 10.15829/1560-4071-2019-8-17-21

6. Gavrilova N.E., Metelskaya V.A., Yarovaya E.B., Boitsov S.A. The role of duplex scanning of the carotid arteries in the detection of coronary atherosclerosis and determining the degree of its severity. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2014; (4): 108–112. [In Russian]. doi: 10.15829/1560-4071-2014-4-108-112

7. Zaitsev D.E., Lepekhina A.S., Trufanov G.E. Ultrasound semiotics of signs of destabilization of atherosclerotic plaques of the carotid arteries. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2019; 24 (12): 70–75. [In Russian]. doi: 10.15829/1560-4071-2019-12-70-75

8. Ragino Yu.I., Volkov A.M., Chernyavsky A.M. Stages of development of the atherosclerotic focus and types of unstable plaques-pathophysiological and histological characteristics. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2013; (5): 88–96. [In Russian].

9. Ragino Yu.I. Unstable atherosclerotic plaque and its laboratory and biochemical markers. Novosibirsk: Nauka, 2019. 120 p. [In Russian].

10. Shalnev V.I. Acute coronary syndrome: how to reduce residual inflammatory risk? Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2020; 25 (2): 113–118. [In Russian]. doi: 10.15829/1560-4071-2020-2-3720

11. Bogatyreva K.B., Azova M.M., Aghajanyan A.V., Tskhovrebova L.V., Ait A.A., Shuguev Z.Kh. Association of polymorphism of the ITGB3 gene with the development of atherosclerosis and in-stent restenosis of the coronary arteries in patients with stable ischemic heart disease. Nauchnyye rezul’taty biomeditsinskikh issledovaniy = Research Results in Biomedicine. 2018; 4 (4): 3–9. [In Russian]. doi: 10.18413/2313-8955-2018-4-4-0-1

12. Yonggang M., Yabluchanskiy A., Hall M.E., Lindsey M.L. Using plasma matrix metalloproteinase-9 and monocyte chemoattractant protein-1 to predict future cardiovascular events in subjects with carotid atherosclerosis. Atherosclerosis. 2014; 232 (1): 231–233. doi: 10.1016/j.atherosclerosis.2013.09.013

13. Stakhneva E.M., Kashtanova E.V., Polonskaya Ya.V., Kamenskaya O.V., Sadovsky E.V., Kurguzov A.V., Chernyavsky A.M., Ragino Yu.I. Evaluation of oxidative stress and antioxidant capacity in patients with coronary atherosclerosis. Molekulyarnaya meditsina = Molecular Medicine. 2016; 14 (2): 56–59. [In Russian].

14. Corrado E., Rizzo M., Coppola G., Fattouch K., Novo G., Marturana I., Ferrara F., Novo S. An update on the role of markers of inflammation in atherosclerosis. J. Atheroscler. Thromb. 2010; 17 (1): 1–11. doi: 10.5551/jat.2600

15. Eurasian Association of Cardiologists. National Society for the Study of Atherosclerosis (NOA). Diagnosis and correction of lipid metabolism disorders for the prevention and treatment of atherosclerosis. Russian recommendations, VII revision. Ateroskleroz i dislipidemii = The Journal of Atherosclerosis and Dyslipidemias. 2020; 38 (1): 7–40. [In Russian]. doi: 10.34687/2219-8202.JAD.2020.01.0002